Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hummel

Showing results (231-240 of 385) with videos related to

Pageof 39
Sort By:
Blood|July 7, 2011
Macrophage development from HSCs requires PU.1-coordinated microRNA expressionSaeed Ghani, Pia Riemke, Jörg Schönheit, et al.
Cells|March 25, 2022
S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and EsophagusChristoph Treese, Kimberly Hartl, Michelle Pötzsch, et al.
Diabetes Care|January 19, 2019
Event Rates and Risk Factors for the Development of Diabetic Ketoacidosis in Adult Patients With Type 1 Diabetes: Analysis From the DPV Registry Based on 46,966 PatientsHannes Kalscheuer, Jochen Seufert, Stefanie Lanzinger, et al.
Lung Cancer (Amsterdam, Netherlands)|November 9, 2015
ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision makingMaximilian von Laffert, Albrecht Stenzinger, Michael Hummel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 10, 2014
First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantationRené Geyeregger, Christine Freimüller, Julia Stemberger, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 19, 2022
The combination of clinical parameters and immunophenotyping of intraepithelial lymphocytes allows to assess disease severity in refractory celiac diseaseFederica Branchi, Jakob Johann Wiese, Claudia Heldt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 27, 2022
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynäkologische Onkologie intergroup analysisBich Doan Nguyen-Sträuli, Joanna Baum, Philipp Meyer-Wilmes, et al.
Cells|July 25, 2019
Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian CancerHagen Kulbe, Raik Otto, Silvia Darb-Esfahani, et al.
BMC Cancer|April 7, 2019
Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphomaKarsten Kleo, Lora Dimitrova, Elisabeth Oker, et al.
British Journal of Haematology|February 13, 2003
Common clonal T-cell origin in a patient with T-prolymphocytic leukaemia and associated cutaneous T-cell lymphomasChalid Assaf, Michael Hummel, Edgar Dippel, et al.
Pageof 39

Showing results (231-240 of 385) with videos related to

Sort By:
Pageof 39
Blood|July 7, 2011
Macrophage development from HSCs requires PU.1-coordinated microRNA expressionSaeed Ghani, Pia Riemke, Jörg Schönheit, et al.
Cells|March 25, 2022
S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and EsophagusChristoph Treese, Kimberly Hartl, Michelle Pötzsch, et al.
Diabetes Care|January 19, 2019
Event Rates and Risk Factors for the Development of Diabetic Ketoacidosis in Adult Patients With Type 1 Diabetes: Analysis From the DPV Registry Based on 46,966 PatientsHannes Kalscheuer, Jochen Seufert, Stefanie Lanzinger, et al.
Lung Cancer (Amsterdam, Netherlands)|November 9, 2015
ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision makingMaximilian von Laffert, Albrecht Stenzinger, Michael Hummel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 10, 2014
First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantationRené Geyeregger, Christine Freimüller, Julia Stemberger, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 19, 2022
The combination of clinical parameters and immunophenotyping of intraepithelial lymphocytes allows to assess disease severity in refractory celiac diseaseFederica Branchi, Jakob Johann Wiese, Claudia Heldt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 27, 2022
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynäkologische Onkologie intergroup analysisBich Doan Nguyen-Sträuli, Joanna Baum, Philipp Meyer-Wilmes, et al.
Cells|July 25, 2019
Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian CancerHagen Kulbe, Raik Otto, Silvia Darb-Esfahani, et al.
BMC Cancer|April 7, 2019
Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphomaKarsten Kleo, Lora Dimitrova, Elisabeth Oker, et al.
British Journal of Haematology|February 13, 2003
Common clonal T-cell origin in a patient with T-prolymphocytic leukaemia and associated cutaneous T-cell lymphomasChalid Assaf, Michael Hummel, Edgar Dippel, et al.
Pageof 39